Neuland Laboratories has reported results for the second quarter ended September 30, 2013. The company has reported 11.68% rise in its net profit at Rs 3.44 crore for the quarter as compared to Rs 3.08 crore for the same quarter in the previous ... Indian-Commodity, 4 weeks ago
Neuland Lab standalone Sep '13 sales at Rs 105.10 crore - Money Control, 1 month ago
Neuland Laboratories net profit rises 11.57% in the September 2013 quarter - Business Standard, 1 month ago
2 images for "neuland laboratories"
Neuland reported EBITDA of $2.33 mn. Neuland Laboratories Ltd, a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customers located in 85 countries, today announced ...India Infoline, 4 weeks ago Neuland Labs Q2 FY14 Results APN News, 1 month ago Neuland Labs Reports Second Quarter Fiscal Year 2014 Financial Results 4 Traders, 1 month ago Neuland Reports Second Quarter Fiscal Year 2014 Financial Results BioSpace, 1 month ago
Hyderabad-based Neuland Laboratories Limited reported an 11.5 per cent increase in net profit at Rs 3.4 crore for the quarter ended September 2013 on marginal improvement in profitability due to lower costs. Its net profit stood at Rs 3 crore in ...Business Standard India, 1 month ago Neuland Q2 profit increases 11.68% to Rs 3.44 cr Business Standard, 1 month ago Neuland Lab Q2 profit up 11.5% to Rs 3.4 cr Business Line, 4 weeks ago
Reportbuyer.com just published a new market research report: Report Details Contracted drug production - discover trends and segments with highest revenue potential Where's outsourced pharma manufacturing heading? Visiongain's updated report ...PRWeb, 4 weeks ago
International revenue of 25 pharma cos up by 27.6% in 2012-13, contributes over 67% to total revenues
Despite stiff competition, frequent quality issues and economic slow down experienced in developed countries, India's top 25 pharmaceutical companies continue to register impressive growth in their international business. A Pharmabiz study of the ...PharmaBiz, 1 month ago
To make clinical R&D sector in India survive and grow, the government should become more practical in its approach while framing policies. Sachin Jagdale reports on current challenges associated with this sector and the way forward to tackle them ...Express Pharma, 2 months ago
on your WebpageAdd Widget >Get your members hooked!